Research Article
Clinicopathological Characteristics and Prognosis of Upper Gastric Cancer Patients in China: A 32-Year Single-Center Retrospective Clinical Study
Table 1
Clinicopathological characteristics of patients with upper and lower gastric cancer.
| | Upper gastric cancer (%) | Lower gastric cancer (%) | value | | |
| | Sex | | | <0.001 | | Male | 531 (81.8) | 1098 (70.8) | | | Female | 118 (18.2) | 453 (29.2) | | | Age (years) | | | 0.003 | | <60 | 303 (46.7) | 833 (53.7) | | | ≥60 | 346 (53.3) | 718 (46.4) | | | Tumor diameter (cm) | | | <0.001 | | <5 | 267 (41.4) | 946 (61.0) | | | ≥5 | 382 (58.9) | 605 (39.0) | | | Tissue type | | | 0.046 | | Well differentiated | 270 (41.6) | 575 (37.1) | | | Poorly differentiated | 379 (58.4) | 976 (62.9) | | | Tissue growth mode | | | <0.001 | | Agglomerate type | 131 (20.2) | 434 (28.0) | | | Nest type | 185 (28.0) | 467 (30.1) | | | Diffuse type | 333 (25.7) | 650 (41.9) | | | Macroscopic type | | | | | Early | 47 (7.2) | 332 (21.4) | <0.001 | | Local (Borrmann 1, 2) | 126 (19.4) | 212 (13.7) | 0.068# | | Infiltrative (Borrmann 3, 4) | 476 (73.4) | 1007 (64.9) | | | pT | | | <0.001 | | T1 | 47 (7.2) | 331 (21.3) | | | T2 | 67 (10.3) | 318 (20.5) | | | T3 | 271 (41.8) | 527 (34.0) | | | T4a | 224 (34.5) | 340 (21.9) | | | T4b | 40 (6.2) | 35 (2.3) | | | pN | | | 0.041 | | N0 | 232 (35.7) | 639 (41.2) | | | N1 | 116 (17.9) | 299 (19.3) | | | N2 | 138 (21.3) | 284 (18.3) | | | N3a | 110 (16.9) | 235 (15.2) | | | N3b | 53 (8.2) | 94 (6.1) | | | Lymphovascular tumor embolus | | | 0.034 | | Positive | 172 (26.5) | 346 (22.3) | | | Negative | 477 (73.5) | 1205 (77.7) | | | Serosal invasion | | | <0.001 | | Positive | 264 (40.7) | 375 (24.2) | | | Negative | 385 (59.3) | 1176 (75.8) | | | Recurrence and metastasis | | | <0.001 | | Positive | 277 (42.7) | 526 (33.9) | | | Negative | 372 (57.3) | 1025 (66.1) | |
|
|
Early versus advanced cancer; #comparison of advanced cancers. |
